7:18 AM ET
8-K
Dividend
Indivior Pharmaceuticals Dividend
Indivior Pharmaceuticals declared a special cash dividend of $8.13 per share to be paid to stockholders of record as of October 30, 2026. The payment is strictly contingent upon the closing of Indivior's pending merger with Supernus Pharmaceuticals, which is expected to occur on or about November 2, 2026. Supernus stockholders will not receive this dividend for shares received as merger consideration.
- Counterparty
- Supernus Pharmaceuticals, Inc.